Barcelona – Pittsburgh
¡Bienvenidos a la XII Conferencia Bienal Barcelona – Pittsburgh!
Te unes a una conferencia que se ha convertido en una referencia en el campo de las demencias. Este año, en junio de 2022, BCNPIT volverá a surgir como un valioso foro donde profesionales de todo el mundo se conectan y comparten su trabajo y perspectivas sobre la demencia.
Se trata de un congreso de gran calidad que reúne a panelistas de reconocido prestigio científico internacional y crea un espacio interactivo relacionado con la neurociencia cuyo objetivo final es beneficiar a las personas afectadas y sus familias.
Dr. Butler research focusses on understanding the memory deficits experienced by patients with damage to the medial temporal lobes of the brainChris Butler, MD, PhD Clinical Senior Lecturer in Neurology at the Imperial College
Vitorica’s group main goal is the characterization of transgenic mice models of AD at the cellular and molecular levels.Javier Vitorica, PhD Principal researcher at Ciberned
The Neurochemistry Laboratory of VUmc aims at developing biomarkers for neurodegenerative diseases.Charlotte Teunissen, PhD Professor in Neurochemistry at VUmc
Currently, Dr. Costa is Director of Plasma Proteins Research of the Grifols Bioscience Research Group, where she is in charge of leading Alzheimer’s Disease research.Montse Costa, PhD Director of the Plasma Proteins Research at the R&D Grifols
Dr. Vellas main interests are: development of aging and geriatric clinical research and care.Bruno Vellas, MD, PhD Department of Geriatric Internal Medicine at the Toulouse University Hospital
Dr. Ikram’s research focuses on investigating the etiology of neurologic diseases in the elderly, with a particular focus on dementia, Alzheimer disease, stroke, and Parkinson disease.Arfan Ikram, MD, PhD Professor and Chair Epidemiology at the Erasmus University Medical Center
The Kristel Sleegers lab is committed to increase insight in the complex genetics of Alzheimer’s disease and to investigate the translational potential of genetic discovery.Kristel Sleegers, MD, PhD Full professor of Genetic Neuroepidemiology at the University of Antwerp
Prof. Heneka is involved in basic science and translational research with focus on neurodegeneration and neuroinflammation.Prof. Michael Heneka, MD Director of the Luxembourg Centre for Systems Biomedicine
Dr. Cohen’s research interests include aging, Alzheimer’s disease and neuroimaging.Ann D Cohen, PhD Associate Professor at the University of Pittsburgh
Dr. Seshadri enjoys a superb reputation in both science and clinical care and is a recognized thought leader in Alzheimer’s disease.Sudha Seshadri, MD Founding director of the Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases
Dr. Zlokovic studies the role of brain microcirculation, particularly the blood-brain barrier (BBB) in health and disease in the adult brain and during brain aging.Berislav V Zlokovic, MD, PhD Director of the Zilkha Neurogenetic Institute
Dr. Cano is in charge of the molecular biology unit of Ace Alzheimer Center Barcelona and her studies are related to the clinical evaluation of early biomarkers of Alzheimer’s disease.Amanda Cano, PhD Postdoctoral researcher at Ace
Dr. Alegret has extensive experience in diagnosis, clinical management, neuropsychological evaluation, cognitive stimulation and research on different neurodegenerative diseasesMontse Alegret, PhD Neuropsychologist at Ace
Neurologist specialist in cognitive disorders with a broad clinical and research experience in Spain and the United States.Marta Marquié, MD, PhD Neurologist at Ace
The main objective of his genomic research group is to understand the causes of Alzheimer’s disease and other dementias by integrating genetic, transcriptomic and proteomic data.Agustín Ruiz, MD, PhD Chief Scientific Officer at Ace